A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia

被引:54
作者
Harrow, Martin [1 ]
Jobe, Thomas H. [1 ]
Faull, Robert N. [1 ]
Yang, Jie [2 ]
机构
[1] Univ Illinois, Coll Med, Dept Psychiat, 1601 W Taylor,M-C 912, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Math Stat & Comp Sci, 851S Morgan S4, Chicago, IL 60607 USA
关键词
Employment; Psychosis; Outcome; Treatment; Negative symptoms; LONG-TERM TREATMENT; 1ST-EPISODE PSYCHOSIS; SUPERSENSITIVITY PSYCHOSIS; NEUROCOGNITIVE DEFICITS; MENTAL-ILLNESS; RECOVERY; REMISSION; PROGNOSIS; MAINTENANCE; PREDICTORS;
D O I
10.1016/j.psychres.2017.06.069
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
To assess the long-term effectiveness of antipsychotic medications in facilitating work functioning in patients with schizophrenia we conducted longitudinal multifollowup research on 139 initially psychotic patients. The 70 patients with schizophrenia and 69 initially psychotic mood disordered control patients were followed up 6 times over 20 years. We compared the influence on work functioning of patients with schizophrenia continuously prescribed antipsychotics with patients with schizophrenia not prescribed antipsychotics, using statistical controls for inter-subject differences. While antipsychotics reduce or eliminate flagrant psychosis for most patients with schizophrenia at acute hospitalizations, four years later and continually until the 20 year followups, patients with schizophrenia not prescribed antipsychotics had significantly better work functioning. The work performance of the patients who were continuously prescribed antipsychotics was at a low rate and did not improve over time. Multiple other factors also interfere with work functioning. The data suggest that some patients with schizophrenia not prescribed antipsychotics for prolonged periods can function relatively well. Multiple other factors are associated with poor post-hospital work performance. The longitudinal data raise questions about prolonged treatment of schizophrenia with antipsychotic medications.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 67 条
[1]   Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study [J].
Alonso, Jordi ;
Croudace, Tim ;
Brown, Jacqueline ;
Gasquet, Isabelle ;
Knapp, Martin R. J. ;
Suarez, David ;
Novick, Diego .
VALUE IN HEALTH, 2009, 12 (04) :536-543
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]  
Barnes S.S., 2016, PSYCHIAT SERV
[4]   The debate over dopamine's role in reward: the case for incentive salience [J].
Berridge, Kent C. .
PSYCHOPHARMACOLOGY, 2007, 191 (03) :391-431
[5]  
BLAND RC, 1978, ARCH GEN PSYCHIAT, V35, P72
[6]  
Bleuler M., 1978, The schizophrenic disorders: Long-term patient and family studies
[7]   Psychosocial treatment, antipsychotic postponement, and low-dose medication strategies in first-episode psychosis: A review of the literature [J].
Bola, John R. ;
Lehtinen, Klaus ;
Cullberg, Johan ;
Ciompi, Luc .
PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2009, 1 (01) :4-18
[8]   Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US [J].
Bond, Gary R. ;
Drake, Robert E. ;
Becker, Deborah R. .
WORLD PSYCHIATRY, 2012, 11 (01) :32-39
[9]   The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements [J].
Buchanan, Robert W. ;
Kreyenbuhl, Julie ;
Kelly, Deanna L. ;
Noel, Jason M. ;
Boggs, Douglas L. ;
Fischer, Bernard A. ;
Himelhoch, Seth ;
Fang, Beverly ;
Peterson, Eunice ;
Aquino, Patrick R. ;
Keller, William .
SCHIZOPHRENIA BULLETIN, 2010, 36 (01) :71-93
[10]  
BUCHSBAUM MS, 1992, ARCH GEN PSYCHIAT, V49, P966